Caveolar and non-Caveolar Caveolin-1 in ocular homeostasis and disease

EN Enyong, JM Gurley, ML De Ieso, WD Stamer… - Progress in retinal and …, 2022 - Elsevier
Caveolae, specialized plasma membrane invaginations present in most cell types, play
important roles in multiple cellular processes including cell signaling, lipid uptake and …

Caveolin-1 in cell migration and metastasis

S Nunez-Wehinger, RJ Ortiz, N Diaz… - Current molecular …, 2014 - ingentaconnect.com
Caveolin-1 is a member of the caveolin family that has been ascribed a dual role in cancer.
In early stages of disease the protein functions predominantly as a tumor suppressor …

Pharmacological and protein profiling suggests venetoclax (ABT-199) as optimal partner with ibrutinib in chronic lymphocytic leukemia

F Cervantes-Gomez, B Lamothe, JA Woyach… - Clinical cancer …, 2015 - AACR
Purpose: Bruton's tyrosine kinase (BTK) is a critical enzyme in the B-cell receptor pathway
and is inhibited by ibrutinib due to covalent binding to the kinase domain. Though ibrutinib …

Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT …

VM Patel, K Balakrishnan, M Douglas, T Tibbitts, EY Xu… - Leukemia, 2017 - nature.com
Duvelisib, an oral dual inhibitor of PI3K-δ and PI3K-γ, is in phase III trials for the treatment of
chronic lymphocytic leukemia (CLL) and indolent non-Hodgkin's lymphoma. In CLL …

Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen

H Fan, G Dong, G Zhao, F Liu, G Yao… - Journal of …, 2014 - Wiley Online Library
The aim of the present study was to investigate mechanism of the gender differences of B
cells. The results showed that 358 differential gene expressions (DEGs) were displayed …

Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease

AK Mittal, NK Chaturvedi, KJ Rai… - Molecular …, 2014 - Springer
Chronic lymphocytic leukemia (CLL) cells survive longer in vivo than in vitro, suggesting that
the tissue microenvironment provides prosurvival signals to tumor cells. Primary and …

Higher gene expression variability in the more aggressive subtype of chronic lymphocytic leukemia

S Ecker, V Pancaldi, D Rico, A Valencia - Genome medicine, 2015 - Springer
Background Chronic lymphocytic leukemia (CLL) presents two subtypes which have
drastically different clinical outcomes, IgVH mutated (M-CLL) and IgVH unmutated (U-CLL) …

Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia

AK Mittal, NK Chaturvedi, RA Rohlfsen, P Gupta… - PloS one, 2013 - journals.plos.org
Earlier, we reported that CTLA4 expression is inversely correlated with CD38 expression in
chronic lymphocytic leukemia (CLL) cells. However, the specific role of CTLA4 in CLL …

Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells

D Shi, Y Liu, R Xi, W Zou, L Wu, Z Zhang… - International Journal …, 2016 - Taylor & Francis
Chronic myelogenous leukemia (CML) is characterized by the t (9; 22)(q34; q11)-associated
Bcr-Abl fusion gene, which is an essential element of clinical diagnosis. As a traditional …

Association between gene and miRNA expression profiles and stereotyped subset# 4 B-cell receptor in chronic lymphocytic leukemia

F Maura, G Cutrona, L Mosca, S Matis… - Leukemia & …, 2015 - Taylor & Francis
In this study we investigated specific biological and clinical features associated with chronic
lymphocytic leukemia (CLL) patients carrying stereotyped BCR subset# 4 (IGHV4–34) …